手机版澳门黄金城网址

The 10th biological medicine industry technology seminar of zhongyuan company Beijing station was successfully held

On August 2, 2018, Beijing zhongyuan company 10th biological medicine industry technology seminar Beijing station was successfully held in xingji pullman hotel, yizhuang, Beijing.Conference invited Sartorius, BD, Alfa Laval, MD, Sciex, Luminex, Filtrox and other international well-known company's technical experts, for biomedical research and development and production of the entire process required for new products and new technology (including clarification filtration, capillary electrophoresis technology, multiple detection technology, large-scale cultivation technology of high density) conducted a wonderful speech.The conference attracted more than 100 professionals from biomedical enterprises and scientific research institutions in Beijing and its surrounding areas, and established a good communication platform for the r&d and production of various enterprises.

He yaoqiang, general manager of industrial business of zhongyuan company, attended the meeting and gave a speech

Sartorius中国区法规事务经理沈亮对“一次性使用系统法规和行业标准更新”进行了主题演讲

BD公司高级生物工艺部门高级工程师寇天赐对“疫苗市场分析及BHK无血清培养基开发”进行了主题演讲

Alfa Laval公司区域销售经理吴昊对“蝶式离心机在生物制药的应用”进行了主题演讲

MD公司酶标仪产品线经理尹迪对“合规之路,何去何从——新一代微孔板检测系统助力生物制药”进行了主题演讲

Sciex公司生物制药部门技术专家高铁对“生物药糖基分析中的利器——hjc电泳进行快速糖基制备与鉴定”进行了主题演讲

Luminex公司现场应用专家陈坤良对“事半功倍的新选择——多重检测技术”进行了主题演讲

北京中原公司首席科学家朱希灿老师对“开发产业化工艺过程,为医药产业升级保驾护航”进行了主题演讲,将时下热门的hjc治疗制备工艺进行了经验分享

Filtrox公司营销总监何群对“高密度培养液/发酵液的澄清过滤”进行了主题演讲

会议期间还抽取一等奖、二等奖和三等奖,中奖人员与参会嘉宾合影留念

Zhongyuan company is committed to building a platform for communication and exchange between domestic biomedical enterprises and foreign well-known enterprises.With continuous efforts, the biomedical industry technology seminar has developed into a meeting with a certain influence in the field of biomedicine in China, and become a platform for exchanges and cooperation between Chinese enterprises in the field of biotechnology and medicine.Zhongyuan will, as always, join hands with domestic biopharmaceutical enterprises to jointly promote the sustainable, healthy and rapid development of China's bio-pharmaceutical industry and play a positive role in promoting China's bio-pharmaceutical industry.

附件:
 
qy88.vip千嬴国际手机登录beplay体育网页版乐天堂官方网站